ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

FFP transfusion did not reduce 30-day mortality in pts undergoing cardiac surgery with excessive bleeding: the PLASMACARD multicenter cohort study

Friday, October 11, 2013

Submitted by

Source

Author(s)

PLASMACARD Study Group

This cohort study looks at the Administration of FFP in bleeding patients after cardiac surgery. it finds no difference in mortality in the FFP group and the no FFP group 

Add comment

Log in or register to post comments